JPMorgan Chase & Co. Has Lowered Expectations for Bath & Body Works (NYSE:BBWI) Stock Price

Bath & Body Works (NYSE:BBWI) had its price objective lowered by equities researchers at JPMorgan Chase & Co. from $26.00 to $15.00 in a research note issued to investors on Thursday,MarketScreener reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 0.44% from the company’s previous close.

Several other equities analysts have also commented on BBWI. Morgan Stanley restated an “equal weight” rating and set a $18.00 price target (down previously from $43.00) on shares of Bath & Body Works in a research report on Friday. Wells Fargo & Company set a $25.00 price objective on shares of Bath & Body Works in a research report on Friday. Jefferies Financial Group decreased their target price on Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a report on Monday, October 13th. Telsey Advisory Group downgraded shares of Bath & Body Works from an “outperform” rating to a “market perform” rating and reduced their price target for the company from $38.00 to $17.00 in a research report on Friday. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th. Seven investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $29.17.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $14.93 on Thursday. The stock has a fifty day moving average of $24.83 and a two-hundred day moving average of $28.25. The company has a market capitalization of $3.08 billion, a price-to-earnings ratio of 4.38, a PEG ratio of 0.86 and a beta of 1.53. Bath & Body Works has a fifty-two week low of $14.96 and a fifty-two week high of $41.87.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm posted $0.49 EPS. The company’s revenue was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. On average, analysts forecast that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Institutional Trading of Bath & Body Works

Institutional investors have recently modified their holdings of the company. Parkside Financial Bank & Trust boosted its stake in Bath & Body Works by 24.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after buying an additional 364 shares in the last quarter. Parallel Advisors LLC boosted its stake in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after purchasing an additional 481 shares in the last quarter. Gabelli Funds LLC grew its holdings in Bath & Body Works by 1.2% during the 3rd quarter. Gabelli Funds LLC now owns 47,536 shares of the company’s stock worth $1,225,000 after acquiring an additional 542 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Bath & Body Works by 3.7% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock valued at $430,000 after purchasing an additional 600 shares in the last quarter. Finally, Natixis Advisors LLC lifted its holdings in Bath & Body Works by 0.7% during the 1st quarter. Natixis Advisors LLC now owns 90,089 shares of the company’s stock worth $2,732,000 after buying an additional 629 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.